CLINICAL-ECONOMIC MODELING ANALYSIS OF HUMAN PAPILLOMAVIRUS (HPV) CO-TESTING WITH GENOTYPING VERSUS PRIMARY HPV TESTING FOR CERVICAL CANCER SCREENING

被引：1
|
作者：
Felix, J. C. [1 ]
Lacey, M. J. [2 ]
Miller, J. D. [2 ]
Lenhart, G. M. [2 ]
Kulkarni, R. [2 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[2] Truven Hlth Analyt, Cambridge, MA USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.651
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMD50
引用
收藏
页码：A353 / A353
页数：1
相关论文
共 50 条
  • [21] The Efficacy of HPV16/18 Genotyping in Women with Pap-/HPV plus Co-testing Results in a Cervical Cancer Screening Population and a Cancer Surveillance Population
    Mousavi, Shima
    Kundu, Uma
    Guo, Ming
    MODERN PATHOLOGY, 2019, 32
  • [22] COST-EFFECTIVENESS OF VARIOUS COMBINATIONS OF HUMAN PAPILLOMAVIRUS (HPV)-BASED TESTING, INCLUDING GENOTYPING FOR HPV 16/18, FOR CERVICAL CANCER SCREENING
    Huh, W.
    Williams, E.
    Bramley, T.
    Huang, J.
    Poulios, N.
    VALUE IN HEALTH, 2013, 16 (03) : A142 - A143
  • [23] Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population-based cervical cancer screening studies from China
    Dun, Changchang
    Yuan, Meiwen
    Zhao, Xuelian
    Hu, Shangying
    Arbyn, Marc
    Zhao, Fanghui
    CANCER MEDICINE, 2024, 13 (11):
  • [24] Human Papillomavirus (HPV) Testing for Secondary Prevention of Cervical Cancer
    Partha Basu
    Smita Joshi
    Rengaswamy Sankaranarayanan
    Current Obstetrics and Gynecology Reports, 2015, 4 (4) : 201 - 212
  • [25] Human Papillomavirus (HPV) Testing for Secondary Prevention of Cervical Cancer
    Basu, Partha
    Joshi, Smita
    Sankaranarayanan, Rengaswamy
    CURRENT OBSTETRICS AND GYNECOLOGY REPORTS, 2015, 4 (04): : 201 - 212
  • [26] Applying a gender lens on human papillomavirus infection: cervical cancer screening, HPV DNA testing, and HPV vaccination
    Ivan Branković
    Petra Verdonk
    Ineke Klinge
    International Journal for Equity in Health, 12
  • [27] Applying a gender lens on human papillomavirus infection: cervical cancer screening, HPV DNA testing, and HPV vaccination
    Brankovic, Ivan
    Verdonk, Petra
    Klinge, Ineke
    INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2013, 12
  • [28] HPV-testing versus HPV-cytology co-testing to predict the outcome after conization
    Bruhn, Laerke Valsoe
    Andersen, Sisse Josephine
    Hariri, Jalil
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2018, 97 (06) : 758 - 765
  • [29] Screening for cervical cancer with Human Papillomavirus testing: stand-alone is preferable over co-testing with cytology
    Liang, Linda
    Einzmann, Thomas
    Zeissig, Sylke Ruth
    Franzen, Arno
    Schwarzer, Katja
    Schauberger, Gunther
    Schriefer, Dirk
    Radde, Kathrin
    Ikenberg, Hans
    Snijders, Peter J. F.
    Meijer, Chris J. L. M.
    Kirkpatrick, Charles J.
    Koelbl, Heinz
    Blettner, Maria
    Klug, Stefanie J.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50 : 139 - 139
  • [30] Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study
    Thomsen, Louise T.
    Kjaer, Susanne K.
    Munk, Christian
    Frederiksen, Kirsten
    Ornskov, Dorthe
    Waldstrom, Marianne
    CLINICAL EPIDEMIOLOGY, 2020, 12 : 203 - 213
12345